Company Filing History:
2 out of 2,168 
2 out of 117 
Years Active: 2015-2016
Title: The Innovative Contributions of Dashnie Naidoo
Introduction
Dashnie Naidoo is a prominent inventor based in Pretoria, South Africa. He has made significant contributions to the field of pharmaceuticals, particularly in the area of dementia treatment. With a total of 2 patents, Naidoo's work focuses on innovative compositions that aim to prevent or treat dementia.
Latest Patents
Naidoo's latest patents include a composition for preventing or treating dementia that comprises extracts of Monsonia species. This pharmaceutical composition and food composition inhibit the formation of β-amyloid and detail a method for preparing the extracts. Another notable patent is a composition containing an arylnaphthalene lignan derivative for preventing and/or treating dementia. This composition includes active ingredients such as Justicidin A, 5-methoxyjusticidin A, and Chinensinaphthol, which aim to ameliorate memory impairment and improve memory.
Career Highlights
Throughout his career, Naidoo has worked with esteemed organizations such as the Korea Institute of Science and Technology and the Council for Scientific and Industrial Research (CSIR). His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical field.
Collaborations
Naidoo has collaborated with notable colleagues, including Hyun Ok Yang and Sung-Kwon Chung. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Dashnie Naidoo's contributions to dementia treatment through his innovative patents highlight his dedication to improving healthcare. His work continues to inspire advancements in pharmaceutical compositions aimed at addressing memory-related conditions.